Related Experiment Videos
DNA Damage Induces a Secretory Program in the Quiescent TME that Fosters Adverse Cancer Phenotypes
Luis Gomez-Sarosi1, Yu Sun2, Ilsa Coleman1
1Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington.
Abstract:
Carcinomas develop in complex environments that include a diverse spectrum of cell types that influence tumor cell behavior. These microenvironments represent dynamic systems that contribute to pathologic processes. Damage to DNA is a notable inducer of both transient and permanent alterations in cellular phenotypes. Induction of a DNA damage secretory program is known to promote adverse tumor cell behaviors such as proliferation, invasion, metastasis, and treatment resistance. However, prior studies designed to identify genotoxic stress-induced factors evaluated actively proliferating in vitro cultures of cells such as fibroblasts as experimental models. Conversely, the vast majority of benign cells in a typical tumor microenvironment (TME) are not proliferating but rather exist in quiescent (i.e., G0) or in terminally differentiated states. In this study, the diversity and magnitude of transcriptional responses to genotoxic damage in quiescent prostate fibroblasts were assessed using gene expression profiling. The secretory damage response in quiescent cells was highly concordant with that of actively dividing cells. Quiescent human prostate stroma exposed to genotoxic agents (e.g., mitoxantrone) in vivo resulted in significant upregulation (2.7- to 5.7-fold; P ≤ 0.01) of growth factors and cytokines including IL1β, MMP3, IL6, and IL8. The paracrine effects of damaged quiescent cells consistently increased the proliferation and invasion of prostate cancer cells and promoted cell survival and resistance to apoptosis following exposure to chemotherapy.Implications: Benign quiescent cells in the TME respond to genotoxic stress by inducing a secretory program capable of promoting therapy resistance. Developing approaches to suppress the secretory program may improve treatment responses. Mol Cancer Res; 15(7); 842-51. ©2017 AACR.
Insights
Genotoxic stress in quiescent prostate fibroblasts triggers a secretory program that enhances cancer cell proliferation, invasion, and therapy resistance. Suppressing this program may improve treatment outcomes.
Area of Science:
- Oncology
- Cell Biology
- Molecular Biology
Background:
- Tumor microenvironments (TME) comprise diverse cell types influencing cancer progression.
- DNA damage can induce cellular phenotypes promoting tumor growth and treatment resistance.
- Previous studies on genotoxic stress focused on actively proliferating cells, not quiescent cells dominant in TME.
Purpose of the Study:
- To assess the transcriptional response to genotoxic damage in quiescent prostate fibroblasts.
- To determine if quiescent cells induce a secretory damage response similar to proliferating cells.
- To investigate the impact of this response on prostate cancer cell behavior and treatment resistance.
Main Methods:
- Gene expression profiling of quiescent human prostate fibroblasts exposed to genotoxic agents.
- In vivo assessment of transcriptional changes in quiescent prostate stroma.
- Co-culture experiments to evaluate the paracrine effects on prostate cancer cells.
Main Results:
- Quiescent fibroblasts exhibited a secretory damage response comparable to actively dividing cells.
- Genotoxic stress significantly upregulated growth factors and cytokines (e.g., IL1β, MMP3, IL6, IL8) in quiescent cells.
- Secreted factors from damaged quiescent cells promoted cancer cell proliferation, invasion, and chemoresistance.
Conclusions:
- Benign quiescent cells in the TME activate a secretory program upon genotoxic stress.
- This program contributes to cancer cell proliferation, invasion, and therapy resistance.
- Targeting this secretory pathway presents a potential strategy to enhance cancer treatment efficacy.